Dosing
Also known as: Dose, Dosage, Dosing regimen
Dosing refers to the amount, frequency, and timing of medication administration required to achieve therapeutic effects. For peptides, proper dosing considers factors like half-life, bioavailability, individual response, and the specific condition being addressed. Dosing is typically expressed in milligrams (mg) or micrograms (mcg).
Last updated: January 21, 2026
Components of a Dosing Regimen
| Component | Definition | Example |
|---|---|---|
| Dose | Amount given at one time | 0.5mg |
| Frequency | How often given | Once weekly |
| Route | How administered | Subcutaneous |
| Duration | How long treatment continues | Ongoing |
| Timing | When to administer | Morning, with food |
Dosing Units for Peptides
Common Units
- mg (milligram) = 0.001 gram
- mcg or μg (microgram) = 0.001 milligram
- IU (International Units) = standardized biological activity unit
Conversions
| From | To | Factor |
|---|---|---|
| 1 mg | mcg | × 1000 |
| 1000 mcg | mg | ÷ 1000 |
Factors Affecting Dosing
Medication Properties
- Half-life (longer = less frequent dosing)
- Bioavailability (affects amount needed)
- Therapeutic index (safety margin)
Patient Factors
- Body weight (some doses are weight-based)
- Kidney function (affects clearance)
- Liver function (affects metabolism)
- Age
- Concurrent medications
Dosing Examples
Semaglutide (Weekly)
| Indication | Typical Dose Range |
|---|---|
| Type 2 diabetes | 0.25-2mg weekly |
| Weight management | 0.25-2.4mg weekly |
Tirzepatide (Weekly)
| Indication | Typical Dose Range |
|---|---|
| Type 2 diabetes | 2.5-15mg weekly |
| Weight management | 2.5-15mg weekly |
Research Peptides (Variable)
Dosing in research settings varies widely and depends on the specific study protocol.
Dosing Frequency Considerations
Once Weekly (e.g., Semaglutide)
- Long half-life allows infrequent dosing
- Better adherence
- Steady drug levels
Once Daily (e.g., Liraglutide)
- Shorter half-life requires daily dosing
- More flexibility to stop/start
- Daily routine integration
Multiple Times Daily
- Very short half-life peptides
- Split doses may improve tolerability
- More complex regimen
Common Dosing Errors
| Error | Consequence | Prevention |
|---|---|---|
| Wrong units (mg vs mcg) | 1000x over/underdose | Double-check units |
| Wrong concentration calculation | Incorrect dose | Use proper math |
| Missed doses | Subtherapeutic levels | Set reminders |
| Double dosing | Increased side effects | Track doses |
Reading Dosing Instructions
Example: “0.5mg subcutaneous once weekly”
- 0.5mg = Amount
- Subcutaneous = Route (under skin)
- Once weekly = Frequency
This tells you: Inject 0.5 milligrams under the skin one time per week.
Frequently Asked Questions
Is a higher dose always better?
No. There’s typically an optimal dose range. Going higher increases side effects without proportional benefit. For GLP-1 agonists, higher doses may offer slightly more weight loss but with more GI side effects.
What if I miss a dose?
Depends on the medication’s half-life and how long until next dose. For weekly medications like semaglutide, if within 5 days of missed dose, take it; if not, skip and resume schedule. Always follow specific product guidance.
Are peptide doses the same for everyone?
Often, approved peptide medications use standardized doses (not weight-based). However, response varies individually, and titration allows finding the optimal dose for each person within approved ranges.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.